These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 1828046)
1. [Patients on anticoagulant therapy. Interpretation of a new test]. Benazzi A; Montebugnoli L Dent Cadmos; 1991 Jan; 59(1):66-70. PubMed ID: 1828046 [TBL] [Abstract][Full Text] [Related]
2. [Role of laboratory monitoring in oral anticoagulant therapy]. D'Angelo G; Calvano D; Giardini C Minerva Med; 1993 Jun; 84(6):313-22. PubMed ID: 8336839 [TBL] [Abstract][Full Text] [Related]
3. [Evaluation of a new chromogenic method for measuring prothrombin time in the control of oral anticoagulant therapy]. Colla G; Corciulo G Boll Soc Ital Biol Sper; 1984 Nov; 60(11):2025-31. PubMed ID: 6525255 [TBL] [Abstract][Full Text] [Related]
4. [The management of dental and maxillofacial surgery patients under anticoagulant therapy]. Hönig JF; Merten HA Dtsch Z Mund Kiefer Gesichtschir; 1991; 15(5):334-9. PubMed ID: 1840096 [TBL] [Abstract][Full Text] [Related]
5. Prothrombin time in the monitoring of oral anticoagulant: a comparison of results using different thromboplastins. Guglielmone HA; Vides MA Ann Biol Clin (Paris); 1990; 48(8):547-50. PubMed ID: 2288441 [TBL] [Abstract][Full Text] [Related]
6. [Control of anticoagulant therapy by using soluble thromboplastin]. Gaĭda AV; Monastyrskiĭ VA; Magerovskiĭ IuV; Torik ZhN Lab Delo; 1989; (10):20-3. PubMed ID: 2481064 [TBL] [Abstract][Full Text] [Related]
7. Control of anticoagulant and antiplatelet therapy. Managing patients with acute thrombotic disorders. Anderson DR; Fernandez LA Can Fam Physician; 1993 Feb; 39():290-4, 297-300, 303-4. PubMed ID: 8495120 [TBL] [Abstract][Full Text] [Related]
8. [Biological monitoring of treatment with antivitamin K. Value of INR and definition of new therapeutic ranges. A study of 73 patients]. Gouin I; Horellou MH; Conard J; Samama M Arch Mal Coeur Vaiss; 1990 Mar; 83(3):357-61. PubMed ID: 2108630 [TBL] [Abstract][Full Text] [Related]
9. Interference of lupus anticoagulants in prothrombin time assays: implications for selection of adequate methods to optimize the management of thrombosis in the antiphospholipid-antibody syndrome. Della Valle P; Crippa L; Garlando AM; Pattarini E; Safa O; Viganò D'Angelo S; D'Angelo A Haematologica; 1999 Dec; 84(12):1065-74. PubMed ID: 10586206 [TBL] [Abstract][Full Text] [Related]
14. ICSH/ICTH recommendations for reporting prothrombin time in oral anticoagulant control. Haematologica; 1985; 70(3):269-70. PubMed ID: 3932161 [No Abstract] [Full Text] [Related]
15. [Control of the treatment with oral anticoagulants and prothrombin time]. Marzouka E Rev Med Chil; 1991 Oct; 119(10):1160-4. PubMed ID: 1845211 [TBL] [Abstract][Full Text] [Related]
16. Fucosylated chondroitin sulfate as a new oral antithrombotic agent. Fonseca RJ; Mourão PA Thromb Haemost; 2006 Dec; 96(6):822-9. PubMed ID: 17139379 [TBL] [Abstract][Full Text] [Related]
17. Measurement of prothrombin time in patients on oral anticoagulant therapy: effect of two different evacuated tubes. D'Angelo G; Villa C Haematologica; 1999 Jul; 84(7):656-7. PubMed ID: 10406912 [No Abstract] [Full Text] [Related]